What could be causing low immunoglobulin levels and low platelets five years after DLBCL treatment?
It's encouraging that you've reached the five-year mark with DLBCL. The low immunoglobulin levels (IgG, IgA, IgM) and low platelet count you're experiencing could be long-term effects from your lymphoma treatment Show Full Answer
What could be causing low immunoglobulin levels and low platelets five years after DLBCL treatment?
It's encouraging that you've reached the five-year mark with DLBCL. The low immunoglobulin levels (IgG, IgA, IgM) and low platelet count you're experiencing could be long-term effects from your lymphoma treatment, particularly if you received chemotherapy or certain targeted therapies.
Some DLBCL treatments can affect your immune system's ability to produce antibodies and may impact bone marrow function, which produces platelets. These effects can sometimes persist for years after treatment ends.
These lab values warrant a conversation with your oncology team. They may want to:
- Monitor your levels more closely with regular blood work
- Check for any signs of lymphoma activity or late relapse
- Evaluate whether you need immunoglobulin replacement therapy
- Assess if your bone marrow function has been affected
- Rule out other causes unrelated to your DLBCL history
Low immunoglobulins can increase infection risk, and low platelets can affect blood clotting. Your healthcare team can help determine if treatment or preventive measures are needed based on your specific situation and symptoms.
Don't hesitate to discuss these concerns with your doctor - even five years out from treatment, ongoing monitoring and management of treatment-related effects is important.
October 31, 2025
Join
Your Privacy Choices
